Value-Added Token Economy

The Rejuve token economy is designed to be a self-sustained economy based upon our primary currency and membership reward token, RJV. The Rejuve economy is made up of both data contributing and non-data contributing network members. Data contributing members receive a unique identifier called a Data NFT (dNFT), a non-fungible and non-transferrable token which serves as a key to not only their personal data record in the Data Commons, but to exclusive network benefits, namely the ability to earn RJV tokens via data contributions in the Longevity app, culminating in the earning of Product NFT (pNFT) shards.

A Product NFT is minted when a “product” (with pre-defined requirements such as patent-pending) is incepted. All members whose data contributed to the inception of that product are proportionally rewarded according to the level of their contribution, in the form of shards of that minted NFT. The first batch of pNFT shards are awarded to initial data contributors (those who made the product possible), while a portion is reserved for future contributors (ex. clinical trial participants).

Ownership of these NFT shards becomes more valuable as product development progresses. The goal is for the invention or innovation to go from a workable idea to a real-world market-ready product. Up to 50% of the original shards that contributors earned can be traded. The other 50% are locked so that data ownership doesn't get lost completely (they can't be "sold out" or used). pNFT shards give RJV at times that have already been set. The dNFT signature can be used in the app to claim these earned RJV. Members of the network who don't contribute data can buy pNFT shards from members who do contribute data, join research stake pools, and get discounts in the App if they have RJV tokens.

Wearable health trackers, digital health monitoring devices, vitamins, biological age and DNA methylation tests, electroencephalograms, whole genome sequencing kits, longevity spas and retreats, and more will all give special discounts to RJV token holders, increasing the token's utility. The ultimate goal is for new therapies derived from network member data to be available in this market as well!